Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Groettrup

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Plos One|March 14, 2015
Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradationJohanna Bialas, Marcus Groettrup, Annette Aichem
Methods in Molecular Medicine|December 9, 2004
Delivery of tumor antigens to dendritic cells using biodegradable microspheresYing Waeckerle-Men, Bruno Gander, Marcus Groettrup
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradationCarolina Otero, Marcus Groettrup, Daniel F Legler
Biomolecules|June 27, 2020
Regulation of Interferon Induction by the Ubiquitin-Like Modifier FAT10Mei Min Mah, Nicola Roverato, Marcus Groettrup
Current Opinion in Immunology|December 11, 2012
The immunoproteasome in antigen processing and other immunological functionsMichael Basler, Christopher J Kirk, Marcus Groettrup
Nature Reviews. Immunology|December 17, 2009
Proteasomes in immune cells: more than peptide producers?Marcus Groettrup, Christopher J Kirk, Michael Basler
Molecular Immunology|March 1, 2019
The ubiquitin-like modifier FAT10 is required for normal IFN-γ production by activated CD8<sup>+</sup> T cellsMei Min Mah, Michael Basler, Marcus Groettrup
FEBS Letters|December 8, 2016
Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10Valentina Spinnenhirn, Annegret Bitzer, Annette Aichem, et al.
Molecular Immunology|February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activationAnnegret Bitzer, Michael Basler, Daniel Krappmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2012
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP miceMarc Mueller, Wilfried Reichardt, Julia Koerner, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Plos One|March 14, 2015
Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradationJohanna Bialas, Marcus Groettrup, Annette Aichem
Methods in Molecular Medicine|December 9, 2004
Delivery of tumor antigens to dendritic cells using biodegradable microspheresYing Waeckerle-Men, Bruno Gander, Marcus Groettrup
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradationCarolina Otero, Marcus Groettrup, Daniel F Legler
Biomolecules|June 27, 2020
Regulation of Interferon Induction by the Ubiquitin-Like Modifier FAT10Mei Min Mah, Nicola Roverato, Marcus Groettrup
Current Opinion in Immunology|December 11, 2012
The immunoproteasome in antigen processing and other immunological functionsMichael Basler, Christopher J Kirk, Marcus Groettrup
Nature Reviews. Immunology|December 17, 2009
Proteasomes in immune cells: more than peptide producers?Marcus Groettrup, Christopher J Kirk, Michael Basler
Molecular Immunology|March 1, 2019
The ubiquitin-like modifier FAT10 is required for normal IFN-γ production by activated CD8<sup>+</sup> T cellsMei Min Mah, Michael Basler, Marcus Groettrup
FEBS Letters|December 8, 2016
Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10Valentina Spinnenhirn, Annegret Bitzer, Annette Aichem, et al.
Molecular Immunology|February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activationAnnegret Bitzer, Michael Basler, Daniel Krappmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2012
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP miceMarc Mueller, Wilfried Reichardt, Julia Koerner, et al.
Pageof 14